“Patholytix provides a step change for the digital peer review of GLP toxicology studies. We now have a platform that puts the pathologist back in control”

Matt Jacobsen

|

AstraZeneca

“Patholytix is the first viewer that adopts from the ground a study-centric approach; combined with its excellent metadata management it makes primary evaluation, peer review and blind assessment of nonclinical toxicology studies very efficient, and in some ways even more efficient than the microscope”

Erio Barale-Thomas

|

Janssen Pharmaceuticals

"I am really a big proponent of this software and what it brings to the pathology profession in terms of the ease of work; it just really simplifies our process of working in almost every single way and there’s no loss of detail. I'm sure it's going to make us all better pathologists"

Dr. Maurice Cary

|

PathologyExperts

“Patholytix makes study evaluation so much easier and faster than the traditional evaluation with the microscope. The ease and speed at which I can evaluate and compare my slides gives me a greater confidence in my final diagnosis”

Aleksandra Zuraw

|

Charles River Laboratories

“Patholytix AI is the right solution to leverage Deep Learning and integrate AI-based approaches into the toxicologic pathology field. Coupled with a viewer tailored to the evaluation of nonclinical safety studies, it combines a user-friendly annotation process and some powerful AI models, together with visual maps of the generated masks and quantitative pathology capabilities, providing valuable diagnostic decision support to the pathologists.”

Sebastien Laurent and Béatrice Gauthier

|

Senior Toxicologic Pathologists at Sanofi